Abstract:Rationale: Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. Radiotherapy has long been an important treatment for GBM. Despite recent advances in tumor radiotherapy, the prognosis of GBM remains poor due to radioresistance. Autophagy has been reported as a basic factor to prolong the survival of tumor under radiation stress, but the molecular mechanism of how autophagy contributes to GBM radioresistance was still lacking. Methods: We established radioresistant GBM cells and identified their protein profiles by Tandem mass tag (TMT) quantitative proteomic analysis, then chose the radioresistant genes based on the TMT analysis of GBM cells and differentially expressed genes (DEGs) analysis of GEO database. Colony formation, flow cytometry, qPCR, western blotting, mRFP-GFP-LC3, transmission electron microscopy, immunofluorescence, and co-IP assays were conducted to investigate the regulation mechanisms among these new-found molecules. Results: Syndecan 1 (SDC1) and Transglutaminase 2 (TGM2) were both overexpressed in the radioresistant GBM cells and tissues, contributing to the dismal prognosis of radiotherapy. Mechanically, after irradiation, SDC1 carried TGM2 from cell membrane into cytoplasm, and transported to lysosomes by binding to flotillin 1 (FLOT1), then TGM2 recognized the betaine homocysteine methyltransferase (BHMT) on autophagosomes to coordinate the encounter between autophagosomes and lysosomes. Conclusions: The SDC1-TGM2-FLOT1-BHMT copolymer, a novel member of the protein complexes involved in the fusion of lysosomes and autophagosomes, maintained the autophagic flux in the irradiated tumor cells and ultimately enhanced radioresistance of GBM, which provides new insights of the molecular mechanism and therapeutic targets of radioresistant GBM.

The Role of Autophagy in Sensitizing Malignant Glioma Cells to Radiation Therapy

Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment

Progress in effect of autophagy on gliomas radiation therapy and chemotherapy and molecular regulating mechanism

Role of autophagy in the sensitization of tumor chemoradiotherapy

The Role of Autophagy in Cancer Radiotherapy.

Induction Of Autophagy Promotes Differentiation Of Glioma-Initiating Cells And Their Radiosensitivity

Autophagy Plays a Role in Promoting Radiosensitivity of Glioma Stem/progenitor Cells by Quercetin

Autophagy: a strategy for malignant gliomas' resistance to therapy.

Hypoxia-Induced Autophagy Is Involved in Radioresistance via HIF1A-Associated Beclin-1 in Glioblastoma Multiforme

SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma

Suppression of autophagy augments the radiosensitizing effects of STAT3 inhibition on human glioma cells.

Blockage of Autophagy in C6 Glioma Cells Enhanced Radiosensitivity Possibly by Attenuating DNA-PK-Dependent DSB Due to Limited Ku Nuclear Translocation and DNA Binding

Autophagy Machinery in Glioblastoma: the Prospect of Cell Death Crosstalk and Drug Resistance with Bioinformatics Analysis.

Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance

Autophagy Mediates Glucose Starvation-Induced Glioblastoma Cell Quiescence and Chemoresistance Through Coordinating Cell Metabolism, Cell Cycle, and Survival

Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors

Autophagy and Tumor Radioresistance

Autophagy Modulation and Its Implications on Glioblastoma Treatment

Autophagy Enhanced the Radioresistance of Non-Small Cell Lung Cancer by Regulating ROS Level under Hypoxia Condition

Knockdown of the DNA-dependent Protein Kinase Catalytic Subunit Radiosensitizes Glioma-Initiating Cells by Inducing Autophagy.